Results

Total Results: 2,024 records

Showing results for "intervention".

2001. new disposition of comments insulin analogues -- jda revs.xls (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
      September 01, 2008 - (Baselines and comparative values after the intervention would be most helpful.)

2002. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
      October 01, 2009 - Layout 1 Background Nearly 2,400 Americans die of cardiovascular disease each day, an average of one death every 36 seconds. Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents, and diabetes mellitus combined. An estimated 79,400,000 American adults (one in …

2003. Traumatic Brain Injury and Depression (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
      April 01, 2011 - Traumatic Brain Injury and Depression Introduction We do not know the extent to which depression contributes to long-term disability following traumatic brain injury (TBI), although depression is one of several potential psychiatric illnesses that may be common following TBI. Major depression may be triggered by phy…

2004. Disposition of Comment Report for Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
      May 20, 2013 - The rate of retention requiring intervention is 0.1% (6/6000) compared to 1.4% overall for capsule

2005. Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
      March 05, 2015 - Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Menopausal Symptoms: Comparative Effectiveness Review of Therapies Draft review available for public comment from Novemb…

2006. Breast-Biopsy-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
      September 01, 2014 - 1 Comparative Effectiveness Review Number 139 Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report Executive Summary Background Approximately one in eight U.S. women will develop breast cancer during her lifetime.1 Because the earliest stages of breast cancer are…

2007. Disposition of Comments_Technical Brief No. 44: Measuring Primary Healthcare Spending (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/primary-healthcare-spending-disposition-comments.pdf
      May 17, 2024 - of this brief is different than typical AHRQ technical briefs in not assessing a specific clinical intervention

2008. Dietary-Supplements Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
      January 01, 2013 - -80 yrs of age; controlled or absent cholesterolemia and hypertension; no hx of diabetes, CVD, intervention

2009. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
      June 07, 2013 - Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer Draft review available for public comm…

2010. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
      January 01, 2015 - publication All events were of mild or moderate intensity and did not require treatment or medical intervention

2011. Comparative Effectiveness of Medications in Patients with Epilepsy (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
      March 01, 2012 - the table, but the average reader may not make the connection that PICOTS stands for population, intervention

2012. Disposition of Comments Report for Comparative Effectiveness Review No. 131 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
      February 25, 2014 - Peer Reviewer-3 Results Page 120: under “Intervention”: “The studies had significant heterogeneity”.

2013. Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
      August 27, 2012 - Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques AHRQ’s Community Forum CENTER FOR MEDICAL TECHNOLOGY POLICY Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria De…

2014. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
      January 01, 2007 - Layout 1 Background Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression (including minor depression) may be serious disabling illnesses. MDD is the most prevalent, affecting more than 16 percent (lifetime) of U.S. adults. In 2000, the U.S. economic burden of depressiv…

2015. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
      April 25, 2013 - Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Ef…

2016. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
      December 31, 2022 - Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review Rapid Evidence Product Version 3.0 (July 2022) Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review What Di…

2017. Research White Paper_Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Data Use and Governance Toolkit (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-research-depression.pdf
      October 01, 2021 - Research White Paper_Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Data Use and Governance Toolkit Research White Paper Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Data Use and Governan…

2018. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
      May 01, 2014 - provides updates on six mentor-mentee pairs that are working together to implement an evidence-based intervention

2019. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
      September 01, 2011 - Layout 1 Background Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: the conventional antipsychotics and the atypical. T…

2020. Disposition of Comments for CER 158 Diagnosis of Gout (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
      February 24, 2016 - Disposition of Comments for CER 158 Diagnosis of Gout Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Diagnosis of Gout Draft review available for public comment from November 4, 2014 to December 2, 2014. Research Review Citation: Newberry SJ, FitzGerald J, Maglione MA, O’…